How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Solid Phase Peptide Synthesis Equipment Market
- By Equipment Type: Automated Peptide Synthesizers, Manual Peptide Synthesizers, Microwave-Assisted Peptide Synthesizers, Parallel Peptide Synthesizers, Continuous Flow Peptide Synthesizers
- By Scale of Synthesis: Analytical Scale Synthesizers, Laboratory Scale Synthesizers, Pilot Scale Synthesizers, Industrial Scale Synthesizers
- By Application: Pharmaceutical Research and Development, Biotechnology Research, Academic and Educational Research, Contract Research Organizations (CROs), Industrial Peptide Manufacturing
- By Synthesis Method: Fmoc Chemistry Synthesizers, Boc Chemistry Synthesizers, Hybrid Chemistry Synthesizers
- By End-User: Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations (CMOs)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Automated Peptide Synthesizers leads By Equipment Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 11 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 286 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 11 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Solid Phase Peptide Synthesis Equipment Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 11 company profiles, forecast to 2033.
Segmentation covered
Equipment Type 5
Scale of Synthesis 4
Application 5
Synthesis Method 3
End-User 4
Companies profiled
CEM Corporation
Biotage AB
Protein Technologies Inc.
CSBio Inc.
Gyros Protein Technologies
Intavis Bioanalytical Instruments AG
Peptide Synthetics Ltd.
AAPPTec Inc.
Shimadzu Corporation
Thermo Fisher Scientific
Bachem Holding AG
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
11 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →CEM Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Biotage AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Protein Technologies Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →CSBio Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Gyros Protein Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Intavis Bioanalytical Instruments AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Peptide Synthetics Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →AAPPTec Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Shimadzu Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Thermo Fisher Scientific
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Bachem Holding AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,953M by 2033 · 10.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Automated Peptide Synthesizers53.6
- Manual Peptide Synthesizers10.3
- Microwave-Assisted Peptide Synthesizers15.3
- Parallel Peptide Synthesizers8.4
- Continuous Flow Peptide Synthesizers12.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,022M → $2,298M · 10.7%
Europe$712.2M → $1,523M · 10.0%
Asia Pacific$650.3M → $1,503M · 11.0%
Latin America$402.6M → $1,013M · 12.2%
Middle East and Africa$309.7M → $650.7M · 9.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.602026
10.602027
10.622028
10.622029
10.642030
10.652031
10.662032
10.672033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- CEM Corporation16.0
- Biotage AB19.2
- Protein Technologies Inc.16.3
- CSBio Inc.8.0
- Gyros Protein Technologies6.7
- Intavis Bioanalytical Instruments AG5.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Equipment Type12.3%
Scale of Synthesis24.5%
Application29.4%
Synthesis Method10.3%
End-User23.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.9
- Europe21.8
- Asia Pacific21.5
- Latin America14.5
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| CEM Corporation | 76 | 98 | 95 | 74 | 95 | 89 | 88 |
| Biotage AB | 88 | 84 | 89 | 81 | 88 | 69 | 83 |
| Protein Technologies Inc. | 79 | 63 | 85 | 77 | 82 | 69 | 76 |
| CSBio Inc. | 78 | 79 | 69 | 62 | 60 | 65 | 69 |
| Gyros Protein Technologies | 53 | 70 | 65 | 67 | 62 | 68 | 64 |
| Intavis Bioanalytical Instruments AG | 56 | 52 | 63 | 70 | 52 | 49 | 57 |
| Peptide Synthetics Ltd. | 44 | 66 | 51 | 62 | 59 | 53 | 56 |
| AAPPTec Inc. | 37 | 44 | 37 | 50 | 56 | 35 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- CEM Corporation
- Biotage AB
- Protein Technologies Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| CEM Corporation | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Biotage AB | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Protein Technologies Inc. | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| CSBio Inc. | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Gyros Protein Technologies | ◐ | ✓ | − | − | − | ◐ |
| Intavis Bioanalytical Instruments AG | − | ◐ | ◐ | − | ◐ | − |
| Peptide Synthetics Ltd. | − | − | − | ◐ | − | ◐ |
| AAPPTec Inc. | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1CEM Corporation88
2Biotage AB83
3Protein Technologies Inc.76
4CSBio Inc.69
5Gyros Protein Technologies64
6Intavis Bioanalytical Instruments AG57
7Peptide Synthetics Ltd.56
8AAPPTec Inc.43
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
CEM CorporationBiotage AB
Challenger2
Strong scale, closing on the leaders.
Protein Technologies Inc.CSBio Inc.
Contender2
Focused players with pockets of strength.
Gyros Protein TechnologiesIntavis Bioanalytical Instruments AG
Niche2
Specialists in a single segment or region.
Peptide Synthetics Ltd.AAPPTec Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Equipment Type in North America, then scale across Solid Phase Peptide Synthesis Equipment Market — a $224M beachhead inside a $2.95B market.
Beachhead (SOM)$224Mobtainable near-term
Serviceable (SAM)$1.20Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Automated Peptide Synthesizers
Best fit — highest urgency & budget in Equipment Type.
Economic buyer76 fit
Manual Peptide Synthesizers
Strong fit — clear ROI and a fast path to value.
End user67 fit
Microwave-Assisted Peptide Synthesizers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Equipment Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Scale of Synthesis & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel31%
Digital / self-serve20%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Equipment Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Solid Phase Peptide Synthesis Equipment Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified25%
Evaluation13%
Closed-won6%
$21.7KCAC
$119KLTV
5.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Solid Phase Peptide Synthesis Equipment Market is a durable-growth opportunity — $958M by 2033, compounding at 6.8%.
TAM · 2025$566Mtoday
TAM · 2033$958Mforecast
CAGR6.8%2027–2033
Cumulative$6.72Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$958MTotal addressable market
SAM$367MServiceable available market
SOM$80MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.8% CAGR
Demand compounds through 2033, outpacing GDP across Equipment Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Equipment Type moving from early to mainstream — durable secular demand.
Consolidation upside
11+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$958MLarge & growingTAM by 2033 at 6.8% CAGR
$367MServiceable nowreachable with today’s model
$80MBeachhead winobtainable near-term share
11+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$747MBear4.4% CAGR
$958MBase6.8% CAGR
$1.23BBull9.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Scale of Synthesis optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Solid Phase Peptide Synthesis Equipment Market — a $937M market by 2033. Plan: grow share from 8.0% to 12.4%.
Market size · 2033$937Mtotal addressable
Market CAGR8.8%2027–2033
Target share12.4%from 8.0% today
Revenue ambition$116Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.0% | 12.4% | On track |
| Revenue | $82M | $116M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 29.7% | 40.0% | On track |
| Customer retention | 86.9% | 92.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Equipment Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Scale of Synthesis capability
A defensible second engine — invest in Scale of Synthesis to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Equipment Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Scale of Synthesis
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $14M capacity & capability investment
- Greenlight bolt-on M&A in Scale of Synthesis
- Authorise North America expansion plan
- Fund R&D program for Equipment Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Solid Phase Peptide Synthesis Equipment Market conversation — a $4.30B market you can size, segment and defend in minutes.
Market size · 2033$4.30Btotal opportunity
Growth4.6%CAGR to 2033
Addressable buyers1,186+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Equipment Type
Goal Grow share in Equipment Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 3 mopayback period
$89K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
11+players profiled in this market
Coverage includes
CEM CorporationBiotage ABProtein Technologies Inc.CSBio Inc.Gyros Protein TechnologiesIntavis Bioanalytical Instruments AGPeptide Synthetics Ltd.AAPPTec Inc.+3 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Solid Phase Peptide Synthesis Equipment Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Solid Phase Peptide Synthesis Equipment Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Solid-phase Oligonucleotide Synthesis Market
Market size, share, segmentation and regional forecast.
$854M market · 2025 base year
View reportSolid Microneedle Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportSolid Microneedle Drug Delivery System Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportSolid Medicines Preparation Equipment Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportSolid Gel Electrocardiogram Electrodes Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportSolid Formulations Drug Delivery Market
Market size, share, segmentation and regional forecast.
$957M market · 2025 base year
View reportSolid Dosage Pharmaceutical Excipients Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportSolid Dosage Form Drug Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportSolid Aseptic Transfer System Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportSolenoid Valve for Medical Equipment Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportSolar Surgical Light Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportSolar Rechargeable Hearing Aids Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.